ARCHIVES

In Brief: US Pharmacopeia Names Advisory Panel For Hematologic And Oncological Disease

This article is from The Cancer Letter archive.

Vol. 22 No. 22 | May 31, 1996

Download PDF Visit The Full Archive

Related Articles

MOPP Consequences, Including Increase In cure Rate, Describe By DeVita

May 25, 1979

NCI, NINCDS Need Patients For Brain, Breast Studies

September 10, 1982

In Brief: Congressional Action Imminent On Cancer Ac Renewal, Hew Money Bills; Veto Threatened

September 8, 1978

Research Regulation: NRC fines NIH for Not Securing Radioactive Materials

September 13, 1996

Duke University Settles 11 Medical Malpractice Cases Related to Potti’s trials

December 9, 2011

CMS Advisors Express Low Confidence In Low-Dose CT Screening for Lung Cancer

May 9, 2014